Simulations Plus, Inc. (NASDAQ: SLP) Q3 2025 Earnings | 07/03/2025
About this video
Simulations Plus, Inc. (NASDAQ: SLP) reported its preliminary Q3 2025 results on July 3, 2025, reflecting ongoing market headwinds and a strategic shift in its operating model. The company expects third-quarter revenue to be between $19 million and $20 million, down from the prior year and below earlier expectations, as pharmaceutical and biotech clients continue to face budget reductions, project cancellations, and delays due to funding uncertainties, drug pricing pressures, and potential tariffs. Despite these challenges, the software segment remained resilient, serving as critical infrastructure for drug development programs, while services revenue proved more sensitive to market volatility. Management announced a strategic reorganization, transitioning from a business unit structure to a functionally driven operating model, with new leadership appointments aimed at enhancing client engagement and sales effectiveness. This marks the final phase of a multi-year transformation to streamline operations, unlock synergies, and focus resources on high-potential growth opportunities. CEO Shawn O’Connor emphasized the company’s commitment to operational efficiency, accelerated software enhancements, and AI-driven innovation, positioning Simulations Plus for sustainable, profitable long-term growth. The company reaffirmed its full-year fiscal 2025 revenue guidance of $76 million to $80 million, with final Q3 results and updated guidance to be released after market close on July 14, 2025. Outlook: Q3 2025: Preliminary revenue of $19–$20 million; final results expected July 14, 2025 FY2025: Revenue guidance of $76–$80 million, subject to adjustment upon final Q3 results Continued focus on operational efficiency, AI innovation, and client-centric growth Strategic reorganization to drive collaboration, platform integration, and long-term value About Inside Ticker: For more expert analysis and real-time updates on Simulations Plus, Inc. (NASDAQ: SLP) and other market movers, follow Inside Ticker and visit InsideTicker.com for in-depth reports, financial insights, and the latest news on leading companies. #SimulationsPlus #SLP #Q32025 #Earnings #Biosimulation #PharmaTech #AI #FinancialResults #Software #Innovation #InvestorUpdate #InsideTicker
Video Stats
More from this category

Dell Technologies Inc. (NYSE: DELL) Q1 2026 Earnings Call | AI Server Demand | 5/30/2025
Inside Ticker

Mama's Creations, Inc. (NASDAQ: MAMA) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker

Sportsman’s Warehouse Holdings, Inc. (NASDAQ: SPWH) Q1 2025 Earnings Call | 6/3/2025
Inside Ticker

Hewlett Packard Enterprise Company (NYSE: HPE) Q2 2025 Earnings Call | 6/3/2025
Inside Ticker

Yext, Inc. (NYSE: YEXT) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker

Elastic N.V. (NYSE: ESTC) Q4 2025 Earnings Call | Cloud Revenue Surges & AI Platform | 5/30/2025
Inside Ticker

CrowdStrike Holdings, Inc. (NASDAQ: CRWD) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker

Zscaler (ZS) Q3 2025 Earnings Call | Revenue Beats & AI Security Highlights | May 2025
Inside Ticker

BARK, Inc. (NYSE: BARK) Q4 2025 Earnings Call | 6/4/2025
Inside Ticker

lululemon athletica inc. (NASDAQ: LULU) Q1 2025 Earnings Call | 6/5/2025
Inside Ticker

Sprinklr, Inc. (NYSE: CXM) Q1 2026 Earnings Call | 6/4/2025
Inside Ticker

Braze, Inc. (NASDAQ: BRZE) Q1 2026 Earnings Call | 6/5/2025
Inside Ticker